ES2189711T3 - Proceso de fabricacion de granulos pulverizados que contienen riboflavina. - Google Patents

Proceso de fabricacion de granulos pulverizados que contienen riboflavina.

Info

Publication number
ES2189711T3
ES2189711T3 ES00108560T ES00108560T ES2189711T3 ES 2189711 T3 ES2189711 T3 ES 2189711T3 ES 00108560 T ES00108560 T ES 00108560T ES 00108560 T ES00108560 T ES 00108560T ES 2189711 T3 ES2189711 T3 ES 2189711T3
Authority
ES
Spain
Prior art keywords
riboflavine
manufacturing process
spray drying
granules containing
drying process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00108560T
Other languages
English (en)
Other versions
ES2189711T5 (es
Inventor
Markus Nowotny
Jean-Claude Tritsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238078&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2189711(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2189711T3 publication Critical patent/ES2189711T3/es
Publication of ES2189711T5 publication Critical patent/ES2189711T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/12—Heterocyclic compounds containing pteridine ring systems containing pteridine ring systems condensed with carbocyclic rings or ring systems
    • C07D475/14—Benz [g] pteridines, e.g. riboflavin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un procedimiento de fabricación de granulados de riboflavina fluidos, sin polvillo, exentos de ligante, dicho procedimiento consiste en someter una suspensión acuosa de cristales de riboflavina de la modificación B/C a un secado por atomización en lecho fluidizado, a un secado de atomización con boquilla de líquido único o a un secado de atomización del tipo disco.
ES00108560T 1999-04-30 2000-04-19 Proceso de fabricacion de granulos pulverizados que contienen riboflavina. Expired - Lifetime ES2189711T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99108476 1999-04-30
EP99108476 1999-04-30

Publications (2)

Publication Number Publication Date
ES2189711T3 true ES2189711T3 (es) 2003-07-16
ES2189711T5 ES2189711T5 (es) 2010-07-28

Family

ID=8238078

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00108560T Expired - Lifetime ES2189711T5 (es) 1999-04-30 2000-04-19 Proceso de fabricacion de granulos pulverizados que contienen riboflavina.

Country Status (16)

Country Link
US (1) US6723346B1 (es)
EP (1) EP1048668B2 (es)
JP (1) JP4965013B2 (es)
KR (1) KR100720202B1 (es)
CN (1) CN1198595C (es)
AT (1) ATE231864T1 (es)
AU (1) AU770320B2 (es)
BR (1) BR0002390A (es)
CA (1) CA2306502A1 (es)
DE (1) DE60001286T3 (es)
DK (1) DK1048668T3 (es)
ES (1) ES2189711T5 (es)
ID (1) ID25698A (es)
MX (1) MXPA00004185A (es)
NO (1) NO318219B1 (es)
TW (1) TWI253347B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219815D0 (en) * 2002-08-24 2002-10-02 Accentus Plc Preparation of small crystals
DE10317051A1 (de) * 2003-04-11 2004-10-21 Basf Ag Verfahren zur Herstellung von Riboflavin der Modifikation B/C in Granulatform
EP1670799B1 (en) * 2003-07-22 2009-09-09 DSM IP Assets B.V. Process for the purification of riboflavin
US8689459B2 (en) * 2006-12-07 2014-04-08 Friesland Brands B.V. Method and apparatus for spray drying and powder produced using said method
CN104961740B (zh) * 2015-06-02 2016-04-27 湖北广济药业股份有限公司 一种含核黄素的固体制剂及其制备方法
EP3876912B1 (en) 2018-11-07 2023-04-19 DSM IP Assets B.V. Medicaments containing riboflavin exhibiting improved flowability

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3882466T2 (de) * 1987-09-18 1993-11-11 Hoffmann La Roche Neue Form des Riboflavins.
DE3819745A1 (de) * 1988-06-10 1989-12-14 Basf Ag Verfahren zur herstellung von auf mikrobiellem wege hergestelltem riboflavin in form von sprueh- oder mikrogranulaten
JP2634285B2 (ja) * 1989-03-28 1997-07-23 積水化学工業株式会社 放射性物質取扱所の被覆材用非灰分性樹脂組成物
DE3927810A1 (de) 1989-08-23 1991-02-28 Basf Ag Riboflavingranulate
US4994458A (en) * 1990-04-30 1991-02-19 Basf Corporation Process for rotary fluid bed granulation of riboflavin
US5236920A (en) * 1990-04-30 1993-08-17 Basf Corporation Granulated riboflavin product having high flowability, high riboflavin content
DE4014262A1 (de) 1990-05-04 1991-11-07 Basf Ag Gut rieselfaehige, nichtstaubende bindemittelfreie riboflavinspruehgranulate oder -mikrogranulate aus reinem riboflavin und ein verfahren zu deren herstellung
US5000888A (en) * 1990-05-23 1991-03-19 Basf Corporation Process for spray drying riboflavin to produce a granulate product having low binder content
JP2000112883A (ja) * 1998-09-24 2000-04-21 Internatl Business Mach Corp <Ibm> 情報処理方法、情報処理装置、情報処理プログラムを格納する記憶媒体
CA2282908A1 (en) 1998-10-19 2000-04-19 F. Hoffmann-La Roche Ag Purification and crystallization process for riboflavin
US6093715A (en) * 1999-03-24 2000-07-25 Basf Aktiengesellschaft Process for producing riboflavin-containing granules

Also Published As

Publication number Publication date
DE60001286T3 (de) 2010-10-28
CN1198595C (zh) 2005-04-27
ES2189711T5 (es) 2010-07-28
JP2000327562A (ja) 2000-11-28
ATE231864T1 (de) 2003-02-15
DE60001286D1 (de) 2003-03-06
EP1048668A2 (en) 2000-11-02
US6723346B1 (en) 2004-04-20
KR100720202B1 (ko) 2007-05-21
MXPA00004185A (es) 2002-03-08
TWI253347B (en) 2006-04-21
NO20002283L (no) 2000-10-31
AU770320B2 (en) 2004-02-19
EP1048668B1 (en) 2003-01-29
EP1048668A3 (en) 2001-03-28
NO20002283D0 (no) 2000-04-28
CN1275375A (zh) 2000-12-06
EP1048668B2 (en) 2010-06-09
AU3018900A (en) 2000-11-02
BR0002390A (pt) 2000-10-31
DK1048668T3 (da) 2003-05-26
ID25698A (id) 2000-11-02
DE60001286T2 (de) 2003-11-06
JP4965013B2 (ja) 2012-07-04
NO318219B1 (no) 2005-02-21
KR20010029668A (ko) 2001-04-06
CA2306502A1 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
MXPA02007632A (es) Derivados de 2-benzotiazolil urea y su uso como inhibidores de proteina cinasa.
WO2000061568A3 (de) Mit zuckerresten substituierte 1,4-benzothiazepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
CA2141874A1 (en) Process for the production of urea granules
HU9801934D0 (en) Process for producing of herbicidal activity substituted aryl-halogenalkyl-pyrazol derivatives
DE3863328D1 (de) Granuliertes produkt.
WO1992020649A3 (en) Substituted 2-carboxyindoles having pharmaceutical activity
SE0003544L (sv) Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
EP0582459A3 (en) Production of microcapsules of water-soluble drugs
NO930773D0 (no) Taxan-derivater, fremstilling derav, samt deres anvendelse som krefthindrende middel
BR0002390A (pt) Processo para preparar grânulos pulverizados contendo riboflavina
EP0994108A4 (en) METHOD FOR PRODUCING 2-HYDROXYBENZAMIDE DERIVATIVES
MX9300875A (es) Procedimiento para la preparacion de compuestos azabiciclicos.
TNSN93008A1 (fr) Procede de reduction de la teneur en formaldehyde de formulations microencapsulees
FR2605833B1 (fr) Epandeur de produits granuleux par projection forcee
ES2006487A6 (es) Procedimiento para desinfectar semillas
AU2001270500A1 (en) Fluid bed process for the production of enzyme granules
BRPI0013751B8 (pt) processo para produção de derivados de ácido naftiridina-3-carboxílico.
BR0305399A (pt) Processo para produção de sulfeto alcalino anidro
IS1606B (is) Aðferð til framleiðslu nýs sýkladrepandi efnasambands Thiomarinol, fengið með ræktun Alteromanas rava SANK 73390
IL135388A0 (en) Process for production of substituted alkylamine or its salts
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
DE69008310D1 (de) Sprühgetrocknetes wasserdispergierbares Düngemittel.
FR2688503B1 (fr) Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1&#39;-biphenyle].
HRP20030543B1 (en) Stable granulates containing s-adenosylmethionine and process for the preparation thereof
IT1295099B1 (it) Processo per la produzione di concimi granulari e relativo impianto di granulazione.